全文获取类型
收费全文 | 932222篇 |
免费 | 66378篇 |
国内免费 | 1345篇 |
专业分类
耳鼻咽喉 | 12972篇 |
儿科学 | 24372篇 |
妇产科学 | 23249篇 |
基础医学 | 132964篇 |
口腔科学 | 28261篇 |
临床医学 | 80557篇 |
内科学 | 183294篇 |
皮肤病学 | 19241篇 |
神经病学 | 72203篇 |
特种医学 | 36858篇 |
外国民族医学 | 79篇 |
外科学 | 152170篇 |
综合类 | 18043篇 |
现状与发展 | 1篇 |
一般理论 | 234篇 |
预防医学 | 61763篇 |
眼科学 | 21313篇 |
药学 | 72567篇 |
3篇 | |
中国医学 | 2162篇 |
肿瘤学 | 57639篇 |
出版年
2018年 | 8977篇 |
2017年 | 7038篇 |
2016年 | 7769篇 |
2015年 | 8874篇 |
2014年 | 12000篇 |
2013年 | 17517篇 |
2012年 | 24123篇 |
2011年 | 25053篇 |
2010年 | 14825篇 |
2009年 | 14287篇 |
2008年 | 24605篇 |
2007年 | 25689篇 |
2006年 | 26489篇 |
2005年 | 25441篇 |
2004年 | 24568篇 |
2003年 | 23615篇 |
2002年 | 23165篇 |
2001年 | 54743篇 |
2000年 | 56552篇 |
1999年 | 46954篇 |
1998年 | 10741篇 |
1997年 | 9472篇 |
1996年 | 9593篇 |
1995年 | 8931篇 |
1994年 | 8283篇 |
1993年 | 7595篇 |
1992年 | 35491篇 |
1991年 | 33915篇 |
1990年 | 32740篇 |
1989年 | 31878篇 |
1988年 | 28998篇 |
1987年 | 28256篇 |
1986年 | 26292篇 |
1985年 | 25145篇 |
1984年 | 17834篇 |
1983年 | 15143篇 |
1982年 | 7796篇 |
1981年 | 6772篇 |
1979年 | 15785篇 |
1978年 | 10605篇 |
1977年 | 9053篇 |
1976年 | 7872篇 |
1975年 | 8629篇 |
1974年 | 10467篇 |
1973年 | 9862篇 |
1972年 | 9358篇 |
1971年 | 8853篇 |
1970年 | 8427篇 |
1969年 | 7926篇 |
1968年 | 7202篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
181.
182.
A two-week elective to introduce first- and second-year medical students to primary care internal medicine was developed and evaluated. Course time is divided between conference sessions (25 percent) provided by full-time clinical faculty members and office experience (75 percent) provided by volunteer clinical faculty members (general internists in private practice and in prepaid health plans). Evaluations by the students (n = 58) who took the elective consisted of a questionnaire assessment of the conference session topics, the student's ability to carry out course objectives, and the preceptor's teaching activities. The conference topics were highly rated, with a mean score of 4.1 on a rating scale ranging from 1 (unfavorable) to 5 (favorable). The course objectives and teaching activities were also well rated, with a mean score of 4.1 and 3.9, respectively, on a rating scale ranging from 1 (none) to 5 (outstanding). 相似文献
183.
184.
185.
186.
187.
The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology 总被引:6,自引:0,他引:6
In order to test its potential application to surgical neuropathology, the monoclonal antibody Ki-67 was used to demonstrate immunohistochemically the proliferating cells in 40 neoplasms of the nervous system. The antibody, which reacts with a nuclear protein expressed in the G1, G2, S, and M phases of the cell cycle, was demonstrated in frozen sections of all lesions. The highest incidence of stained nuclei was found in a metastatic carcinoma (57%). The percentage of stained cells in gliomas was in general agreement with the histologic grade and known biologic behavior of the lesions, ranging from 0.6% in a pilocytic astrocytoma to 12.4% in a glioblastoma multiforme. In the fibrillary astrocytic neoplasms of low cellularity, there were good correlations between the percentages of stained cells and the degrees of nuclear pleomorphism and chromatin density. In meningiomas, schwannomas, and a cerebellar hemangioblastoma, the fractions of labeled nuclei were less than 1%. The percentage of stained cells in pituitary adenomas showed considerable variation among the four cases (0.2-1.5%), the biologic significance of which is unknown. In four of the above cases, Ki-67 staining was performed on air-dried squash preparations with excellent visualization of immunoreactive nuclei. In one case, a hemangioblastoma, no stained nuclei were seen. The results confirm that Ki-67 staining is technically suitable as a diagnostic method, with good correlations between frozen sections and smear preparations. Determination of the replicating cell fraction could become an important additional criterion to predict the biologic behavior of nervous system neoplasms. 相似文献
188.
Horner's syndrome or oculosympathetic paralysis is not an uncommon finding in patients with head and neck neoplasms. While in most cases the syndrome is easily established at the bedside, it can be confirmed and topographically defined as a central, preganglionic, or postganglionic lesion through sequential pharmacologic testing. The importance of such localization lies in differentiating neoplasia vs. a benign condition as the cause of the syndrome. Such variants as congenital Horner's, an alternating Horner's, and a pseudo-Horner's syndrome are discussed in regard to their differential features. 相似文献
189.
Sally M. Bradberry Sarah A. Cage Alex T. Proudfoot J. Allister Vale 《Adverse drug reactions and toxicological reviews》2005,24(2):93-106
The first pyrethroid pesticide, allethrin, was identified in 1949. Allethrin and other pyrethroids with a basic cyclopropane carboxylic ester structure are type I pyrethroids. The insecticidal activity of these synthetic pyrethroids was enhanced further by the addition of a cyano group to give α-cyano (type II) pyrethroids, such as cypermethrin. The finding of insecticidal activity in a group of phenylacetic 3-phenoxybenzyl esters, which lacked the cyclopropane ring but contained the α-cyano group (and hence were type II pyrethroids) led to the development of fenvalerate and related compounds. All pyrethroids can exist as at least four stereoisomers, each with different biological activities. They are marketed as racemic mixtures or as single isomers. In commercial formulations, the activity of pyrethroids is usually enhanced by the addition of a synergist such as piperonyl butoxide, which inhibits metabolic degradation of the active ingredient. Pyrethroids are used widely as insecticides both in the home and commercially, and in medicine for the topical treatment of scabies and headlice. In tropical countries mosquito nets are commonly soaked in solutions of deltamethrin as part of antimalarial strategies. Pyrethroids are some 2250 times more toxic to insects than mammals because insects have increased sodium channel sensitivity, smaller body size and lower body temperature. In addition, mammals are protected by poor dermal absorption and rapid metabolism to non-toxic metabolites. The mechanisms by which pyrethroids alone are toxic are complex and become more complicated when they are co-formulated with either piperonyl butoxide or an organophosphorus insecticide, or both, as these compounds inhibit pyrethroid metabolism. The main effects of pyrethroids are on sodium and chloride channels. Pyrethroids modify the gating characteristics of voltage-sensitive sodium channels to delay their closure. A protracted sodium influx (referred to as a sodium ‘tail current’) ensues which, if it is sufficiently large and/or long, lowers the action potential threshold and causes repetitive firing; this may be the mechanism causing paraesthesiae. At high pyrethroid concentrations, the sodium tail current may be sufficiently great to prevent further action potential generation and ‘conduction block’ ensues. Only low pyrethroid concentrations are necessary to modify sensory neurone function. Type II pyrethroids also decrease chloride currents through voltage-dependent chloride channels and this action probably contributes the most to the features of poisoning with type II pyrethroids. At relatively high concentrations, pyrethroids can also act on GABA-gated chloride channels, which may be responsible for the seizures seen with severe type II poisoning. Despite their extensive world-wide use, there are relatively few reports of human pyrethroid poisoning. Less than ten deaths have been reported from ingestion or following occupational exposure. Occupationally, the main route of pyrethroid absorption is through the skin. Inhalation is much less important but increases when pyrethroids are used in confined spaces. The main adverse effect of dermal exposure is paraesthesiae, presumably due to hyperactivity of cutaneous sensory nerve fibres. The face is affected most commonly and the paraesthesiae are exacerbated by sensory stimulation such as heat, sunlight, scratching, sweating or the application of water. Pyrethroid ingestion gives rise within minutes to a sore throat, nausea, vomiting and abdominal pain. There may be mouth ulceration, increased secretions and/or dysphagia. Systemic effects occur 4–8 hours after exposure. Dizziness, headache and fatigue are common, and palpitations, chest tightness and blurred vision less frequent. Coma and convulsions are the principal life-threatening features. Most patients recover within 6 days, although there were seven fatalities among 573 cases in one series and one among 48 cases in another. Management is supportive. As paraesthesiae usually resolve in 12–24 hours, specific treatment is not generally required, although topical application of dl-α tocopherol acetate (vitamin E) may reduce their severity. 相似文献
190.